Search research articles
Contact Us
Filters
Showing results (81-90 of 96) with videos related to
Page
of 10
Sort By:
Journal of the American Heart Association
|
September 13, 2021
LVS-HARMED Risk Score for Incident Heart Failure in Patients With Atrial Fibrillation Who Present to the Emergency Department: Data from a World-Wide Registry
Linda S B Johnson, Jonas Oldgren, Tyler W Barrett, et al.
Open Heart
|
June 26, 2021
Interhospital and interindividual variability in secondary prevention: a comparison of outpatients with a history of chronic coronary syndrome versus outpatients with a history of acute coronary syndrome (the iASPIRE Study)
James Mg Curneen, Conor Judge, Bryan Traynor, et al.
Nature Communications
|
April 21, 2021
RAC1B modulates intestinal tumourigenesis via modulation of WNT and EGFR signalling pathways
Victoria Gudiño, Sebastian Öther-Gee Pohl, Caroline V Billard, et al.
Nutrients
|
February 13, 2025
UK Patient Access to Low-Protein Prescription Foods in Phenylketonuria (PKU): An Uneasy Path
Sharon Evans, Cameron Arbuckle, Catherine Ashmore, et al.
The Lancet. Oncology
|
July 6, 2023
Which patients with metastatic hormone-sensitive prostate cancer benefit from docetaxel: a systematic review and meta-analysis of individual participant data from randomised trials
Claire L Vale, David J Fisher, Peter J Godolphin, et al.
The Lancet. Oncology
|
April 30, 2026
On-treatment serum prostate-specific antigen and overall survival in prostate cancer (STAMPEDE platform protocol): a post-hoc analysis of data from five phase 3 trials
Mahaz Kayani, Laura Murphy, Peter Dutey-Magni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 10, 2021
Quality of Life in Men With Prostate Cancer Randomly Allocated to Receive Docetaxel or Abiraterone in the STAMPEDE Trial
Hannah L Rush, Laura Murphy, Alicia K Morgans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2022
Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST)
Johnathan K Joffe, Fay H Cafferty, Laura Murphy, et al.
The Lancet. Digital Health
|
June 4, 2025
External validation of a digital pathology-based multimodal artificial intelligence-derived prognostic model in patients with advanced prostate cancer starting long-term androgen deprivation therapy: a post-hoc ancillary biomarker study of four phase 3 randomised controlled trials of the STAMPEDE platform protocol
Charles T A Parker, Larissa Mendes, Vinnie Y T Liu, et al.
Cell
|
August 27, 2025
Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancers
Emily Grist, Peter Dutey-Magni, Marina A Parry, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 96) with videos related to
Sort By:
Page
of 10
Journal of the American Heart Association
|
September 13, 2021
LVS-HARMED Risk Score for Incident Heart Failure in Patients With Atrial Fibrillation Who Present to the Emergency Department: Data from a World-Wide Registry
Linda S B Johnson, Jonas Oldgren, Tyler W Barrett, et al.
Open Heart
|
June 26, 2021
Interhospital and interindividual variability in secondary prevention: a comparison of outpatients with a history of chronic coronary syndrome versus outpatients with a history of acute coronary syndrome (the iASPIRE Study)
James Mg Curneen, Conor Judge, Bryan Traynor, et al.
Nature Communications
|
April 21, 2021
RAC1B modulates intestinal tumourigenesis via modulation of WNT and EGFR signalling pathways
Victoria Gudiño, Sebastian Öther-Gee Pohl, Caroline V Billard, et al.
Nutrients
|
February 13, 2025
UK Patient Access to Low-Protein Prescription Foods in Phenylketonuria (PKU): An Uneasy Path
Sharon Evans, Cameron Arbuckle, Catherine Ashmore, et al.
The Lancet. Oncology
|
July 6, 2023
Which patients with metastatic hormone-sensitive prostate cancer benefit from docetaxel: a systematic review and meta-analysis of individual participant data from randomised trials
Claire L Vale, David J Fisher, Peter J Godolphin, et al.
The Lancet. Oncology
|
April 30, 2026
On-treatment serum prostate-specific antigen and overall survival in prostate cancer (STAMPEDE platform protocol): a post-hoc analysis of data from five phase 3 trials
Mahaz Kayani, Laura Murphy, Peter Dutey-Magni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 10, 2021
Quality of Life in Men With Prostate Cancer Randomly Allocated to Receive Docetaxel or Abiraterone in the STAMPEDE Trial
Hannah L Rush, Laura Murphy, Alicia K Morgans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2022
Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST)
Johnathan K Joffe, Fay H Cafferty, Laura Murphy, et al.
The Lancet. Digital Health
|
June 4, 2025
External validation of a digital pathology-based multimodal artificial intelligence-derived prognostic model in patients with advanced prostate cancer starting long-term androgen deprivation therapy: a post-hoc ancillary biomarker study of four phase 3 randomised controlled trials of the STAMPEDE platform protocol
Charles T A Parker, Larissa Mendes, Vinnie Y T Liu, et al.
Cell
|
August 27, 2025
Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancers
Emily Grist, Peter Dutey-Magni, Marina A Parry, et al.
Page
of 10